Filing Details
- Accession Number:
- 0001209191-19-062303
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-31 17:00:11
- Reporting Period:
- 2019-12-27
- Accepted Time:
- 2019-12-31 17:00:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1728117 | Gossamer Bio Inc. | GOSS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1553335 | Jakob Dupont | 3013 Science Park Road San Diego CA 92121 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-27 | 1,994 | $10.71 | 1,994 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-27 | 1,994 | $15.81 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-12-30 | 40,000 | $10.71 | 40,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-12-30 | 40,000 | $15.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified stock option (Right to Buy) | Disposition | 2019-12-27 | 1,994 | $0.00 | 1,994 | $10.71 |
| Common Stock | Non-qualified stock option (Right to Buy) | Disposition | 2019-12-30 | 40,000 | $0.00 | 40,000 | $10.71 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 479,317 | 2028-12-13 | No | 4 | M | Direct | |
| 439,317 | 2028-12-13 | No | 4 | M | Direct |
Footnotes
- The option was granted on December 14, 2018. 25% of the total number of shares subject to the option vested on December 14, 2019 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date.
Billionaire Hedge Funds
